Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.

Zangari M, Saghafifar F, Anaissie E, Badros A, Desikan R, Fassas A, Mehta P, Morris C, Toor A, Whitfield D, Siegel E, Barlogie B, Fink L, Tricot G.

Blood Coagul Fibrinolysis. 2002 Apr;13(3):187-92.

PMID:
11943931
[PubMed - indexed for MEDLINE]
2.

The blood coagulation mechanism in multiple myeloma.

Zangari M, Saghafifar F, Mehta P, Barlogie B, Fink L, Tricot G.

Semin Thromb Hemost. 2003 Jun;29(3):275-82. Review.

PMID:
12888931
[PubMed - indexed for MEDLINE]
3.

Thalidomide and CC-5013 in multiple myeloma: the University of Arkansas experience.

Barlogie B.

Semin Hematol. 2003 Oct;40(4 Suppl 4):33-8. Review.

PMID:
15015894
[PubMed - indexed for MEDLINE]
4.

Thalidomide with or without dexamethasone for refractory or relapsing multiple myeloma.

Alexanian R, Weber D, Anagnostopoulos A, Delasalle K, Wang M, Rankin K.

Semin Hematol. 2003 Oct;40(4 Suppl 4):3-7. Review.

PMID:
15015890
[PubMed - indexed for MEDLINE]
5.

Thalidomide and dexamethasone: therapy for multiple myeloma.

Kumar S, Rajkumar SV.

Expert Rev Anticancer Ther. 2005 Oct;5(5):759-66. Review.

PMID:
16221046
[PubMed - indexed for MEDLINE]
6.

Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease.

Rajkumar SV.

Semin Hematol. 2003 Oct;40(4 Suppl 4):17-22. Review.

PMID:
15015892
[PubMed - indexed for MEDLINE]
7.

Congenital and acquired activated protein C resistance.

Nicolaes GA, Dahlbäck B.

Semin Vasc Med. 2003 Feb;3(1):33-46. Review.

PMID:
15199491
[PubMed - indexed for MEDLINE]
8.

Thrombotic complications in multiple myeloma: a report of three cases and review of the literature.

Ipek Y, Fehmi H, Sevgi BK, Deniz S.

J Thromb Thrombolysis. 2012 Feb;33(2):197-201. doi: 10.1007/s11239-011-0636-z. Review.

PMID:
21904842
[PubMed - indexed for MEDLINE]
9.

Activated protein C resistance: the most common risk factor for venous thromboembolism.

Sheppard DR.

J Am Board Fam Pract. 2000 Mar-Apr;13(2):111-5. Review.

PMID:
10764192
[PubMed - indexed for MEDLINE]
10.

Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.

Fassas AB, Muwalla F, Berryman T, Benramdane R, Joseph L, Anaissie E, Sethi R, Desikan R, Siegel D, Badros A, Toor A, Zangari M, Morris C, Angtuaco E, Mathew S, Wilson C, Hough A, Harik S, Barlogie B, Tricot G.

Br J Haematol. 2002 Apr;117(1):103-8. Review.

PMID:
11918539
[PubMed - indexed for MEDLINE]
11.

Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis.

Uaprasert N, Voorhees PM, Mackman N, Key NS.

Eur J Cancer. 2010 Jul;46(10):1790-9. doi: 10.1016/j.ejca.2010.03.007. Epub 2010 Apr 10. Review.

PMID:
20385482
[PubMed - indexed for MEDLINE]
12.

Thrombosis in multiple myeloma.

Kristinsson SY.

Hematology Am Soc Hematol Educ Program. 2010;2010:437-44. doi: 10.1182/asheducation-2010.1.437. Review.

PMID:
21239832
[PubMed - indexed for MEDLINE]
Free Article
13.

[Analysis of phenotype resistance to activated protein C (APC resistance)].

Hudecek J, Ivanková J, Dobrotová M, Hybenová J, Pullmann R, Kubisz P.

Vnitr Lek. 1999 Dec;45(12):723-8. Review. Czech.

PMID:
10951849
[PubMed - indexed for MEDLINE]
14.

APC resistance and third-generation oral contraceptives: Acquired resistance to activated protein C, oral contraceptives and the risk of thromboembolic disease.

Gris JC, Jamin C, Benifla JL, Quere I, Madelenat P, Mares P.

Hum Reprod. 2001 Jan;16(1):3-8. Review.

PMID:
11139527
[PubMed - indexed for MEDLINE]
Free Article
15.

Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literature.

Martin MG, Vij R.

Clin Lymphoma Myeloma. 2009 Aug;9(4):320-3. doi: 10.3816/CLM.2009.n.063. Review.

PMID:
19717384
[PubMed - indexed for MEDLINE]
16.

[From pill to pill: oral contraception, venous thrombosis and coagulation disorders].

Vandenbroucke JP.

Verh K Acad Geneeskd Belg. 2001;63(3):243-52; discussion 252-5. Review. Dutch.

PMID:
11499345
[PubMed - indexed for MEDLINE]
17.

The phenomenon known as acquired activated protein C resistance.

Clark P, Walker ID.

Br J Haematol. 2001 Dec;115(4):767-73. Review. No abstract available.

PMID:
11843807
[PubMed - indexed for MEDLINE]
18.

Thrombophilia and activated protein C resistance.

Selzman CH, Whitehill TA, Krupski WC.

Ann Vasc Surg. 1998 Nov;12(6):601-4. Review.

PMID:
9841693
[PubMed - indexed for MEDLINE]
19.

The diagnosis and clinical manifestations of activated protein C resistance: a case report and review of the literature.

Hoerl HD, Tabares A, Kottke-Marchant K.

Vasc Med. 1996;1(4):275-80. Review.

PMID:
9552583
[PubMed - indexed for MEDLINE]
20.

Bleeding and thrombosis in multiple myeloma and related plasma cell disorders.

Coppola A, Tufano A, Di Capua M, Franchini M.

Semin Thromb Hemost. 2011 Nov;37(8):929-45. doi: 10.1055/s-0031-1297372. Epub 2011 Dec 23. Review.

PMID:
22198858
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk